Punt, C. J., Voest, E. E., Tueni, E., Van Oosterom, A. T., Backx, A., De Mulder, P. H., . . . Bleiberg, H. (1997). Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer. Nature Publishing Group.
Citación estilo ChicagoPunt, C. J., et al. Phase IB Study of Doxorubicin in Combination With the Multidrug Resistance Reversing Agent S9788 in Advanced Colorectal and Renal Cell Cancer. Nature Publishing Group, 1997.
Cita MLAPunt, C. J., et al. Phase IB Study of Doxorubicin in Combination With the Multidrug Resistance Reversing Agent S9788 in Advanced Colorectal and Renal Cell Cancer. Nature Publishing Group, 1997.
Precaución: Estas citas no son 100% exactas.